Key facts
- It has raised $10K; the latest was Seed Round ($10K) in Apr 2026.
- Myra EB Systems has filed 1 Form D with the SEC, most recently Apr 2026 ($10K sold to 1 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Myra EB Systems
- ·The full record, as it builds
Funding rounds
No funding rounds for Myra EB Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Myra EB Systems
Developer of modular AI-powered software designed to optimize and streamline drug development, manufacturing, and commercialization processes. The company's platform features distinct modules for clinical trial design, radiology report analysis, patient phenotyping, data analytics, predictive maintenance, quality control, supply chain management, and commercial forecasting, enabling pharmaceutical companies and medical organizations to accelerate drug development, improve operational efficiency, and enhance decision-making across the entire drug lifecycle.
- Sector
- Healthcare
- HQ
- Boxborough, MA, United States
- Founded
- 2019
- Employees
- 2
- Website
- myraebsystems.com/
- Ownership
- Privately Held (backing)
Myra EB Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Myra EB Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Myra EB Systems in its N-PORT filings yet. We sweep new filings monthly.